Kidiamix G Start

Valine, Acetylcysteine, Alanine, Arginine, Histidine, Isoleucine, Leucine, Methionine and Phenylalanine, the active ingredients in Kidiamix G Start, are an amino acid supplement presented as a solution for injection for parenteral use. It provides essential amino acids required for protein synthesis and metabolic processes in infants and children receiving parenteral nutrition.

GNH USA supplies Kidiamix G Start as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Kidiamix G Start, an amino acid solution for parenteral nutrition, supports protein synthesis and metabolic needs in pediatric patients.

- Parenteral nutrition in infants and children: Supplies essential amino acids to meet nutritional requirements when enteral feeding is not possible. - Support of growth and development in pediatric patients: Provides building blocks for tissue synthesis and growth during critical developmental periods. - Post‑operative nutritional support in children: Helps maintain nitrogen balance and promotes recovery after surgery. - Metabolic disorders requiring amino acid supplementation: Assists in correcting deficiencies in essential amino acids.

Kidiamix G Start may be associated with a range of adverse reactions, most of which are related to its intravenous administration and the metabolic load of amino acids.

Common Side Effects: - Injection site erythema or pain. - Transient hyperglycemia due to dextrose in the carrier solution. - Mild electrolyte disturbances (e.g., potassium shifts). - Nausea or vomiting when administered rapidly. - Mild increase in serum urea nitrogen.

Serious or Rare Side Effects: - Anaphylactic or severe hypersensitivity reactions. - Hyperammonemia in patients with impaired hepatic function. - Severe electrolyte imbalances (e.g., hyperkalemia, hyperphosphatemia). - Metabolic acidosis from excessive amino acid catabolism. - Thrombophlebitis at the infusion site. - Renal dysfunction in patients with pre‑existing kidney disease.

Kidiamix G Start should be used with careful clinical monitoring to minimise risks.

- Renal function: Assess baseline kidney function and monitor serum creatinine during therapy. - Hepatic function: Evaluate liver enzymes, especially in patients with known liver disease. - Electrolyte balance: Check serum electrolytes before and during infusion. - Inborn errors of metabolism: Avoid in patients with specific amino‑acid metabolic disorders unless specifically indicated. - Compatibility: Verify compatibility with other intravenous solutions before mixing. - Store at 2-8°C: Keep refrigerated, protect from light, do not freeze or shake.

Kidiamix G Start may interact with other intravenous therapies and metabolic modulators.

Major Interactions (Avoid): - Calcium‑containing solutions: Can precipitate amino acids, leading to catheter blockage. - High‑dose parenteral glutamine: May increase nitrogen load and risk of hyperammonemia. - Certain antibiotics (e.g., ceftriaxone) that form insoluble complexes with amino acids.

Moderate Interactions (Monitor Closely): - Renal replacement therapy: May alter amino acid clearance, requiring dose adjustment. - Concurrent electrolyte infusions: May necessitate electrolyte monitoring and adjustment. - Other components of total parenteral nutrition (lipids, dextrose): Require balancing to avoid metabolic overload.